Intravitreal injection ranibizumab: Clinical Trials

2 trials of Intravitreal injection ranibizumab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow Intravitreal injection ranibizumab: new trials by email Literature Review of Intravitreal injection ranibizumab trials Research Report on Intravitreal injection ranibizumab

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ranibizumab to Treat Type 2 Idiopathic Macular Telangiectasia (RAMA-Trial)
Intravitreal injection ranibizumab - Type 2 Idiopathic Macular Telangiectasia
Phase 2CompletedUniversity Hospital, Bonn102007-08-012009-09-22
Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE)
Intravitreal injection ranibizumab - Choroidal Neovascularization
Phase 2CompletedUniversity Hospital, Bonn102007-08-012012-06-15

Conditions studied

Angioid Streaks (1)  ·  Choroidal Neovascularization (1)  ·  Pseudoxanthoma Elasticum (1)

Sponsors

University Hospital, Bonn (2)

Countries

Germany (2)

Top investigators

Hendrik PN Scholl, MD, MA (2)  ·  Frank G. Holz, MD (1)  ·  Frank Holz, MD (1)

Results publications

PMID 20877651, PMID 21334595, PMID 21704964